Genenta Science S.p.A.
NASDAQ:GNTA
4.86 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 3.694 | 29.795 | 37.24 | 15.465 | 20.141 |
Short Term Investments
| 15.097 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 18.791 | 29.795 | 37.24 | 15.465 | 20.141 |
Net Receivables
| 0.834 | 1.562 | 1.421 | 0.761 | 0.43 |
Inventory
| 0 | 0.145 | 0.076 | 0.028 | -0.163 |
Other Current Assets
| 1.649 | 0.219 | 0.022 | 0.281 | 0.192 |
Total Current Assets
| 21.274 | 31.721 | 38.759 | 16.534 | 20.599 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 0.083 | 0.112 | 0.023 | 0.019 | 0 |
Goodwill
| 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0.798 | 0 | 0 | 0 | 0 |
Tax Assets
| -0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.211 | 1.605 | 1.245 | 0.949 | 0.749 |
Total Non-Current Assets
| 1.092 | 1.716 | 1.268 | 0.968 | 0.749 |
Total Assets
| 22.366 | 33.438 | 40.027 | 17.502 | 21.348 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 0.295 | 1.194 | 0.19 | 0.555 | 0.572 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 1.442 | 0.989 | 0.945 | 1.778 | 1.914 |
Total Current Liabilities
| 1.737 | 2.184 | 1.135 | 2.333 | 2.486 |
Non-Current Liabilities: | |||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.179 | 0.116 | 0.031 | 0.017 | 0.011 |
Total Non-Current Liabilities
| 0.179 | 0.116 | 0.031 | 0.017 | 0.011 |
Total Liabilities
| 1.916 | 2.3 | 1.166 | 2.351 | 2.497 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
Common Stock
| 67.4 | 66.604 | 65.881 | 0.037 | 0.036 |
Retained Earnings
| -47.182 | -35.466 | -27.02 | -21.49 | -15.898 |
Accumulated Other Comprehensive Income/Loss
| 0.231 | 0 | 0 | -0 | -0 |
Other Total Stockholders Equity
| -0 | 0 | 0 | 36.605 | 34.713 |
Total Shareholders Equity
| 20.449 | 31.138 | 38.861 | 15.151 | 18.851 |
Total Equity
| 20.449 | 31.138 | 38.861 | 15.151 | 18.851 |
Total Liabilities & Shareholders Equity
| 22.366 | 33.438 | 40.027 | 17.502 | 21.348 |